Loading company…
Shanghai Dingxin Gene Technology develops gene therapy drugs and delivery technologies.
Shanghai Dingxin Gene Technology develops gene therapy and other specialized drugs for ophthalmology, otology, cardiovascular disease, tumors, and the central nervous system. The company also provides technical consulting, services, development, and technology transfer. Founded in 2020, it is based in Shanghai, where it established a gene therapy research and development center in 2021. It planned to use pre-Series A funding for preclinical development and delivery platform construction.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in